Remdesivir Maker Gilead Sciences Declares Dividend; Yield Is 3.9%
Although it isn't particularly famed as a dividend stock, Gilead Sciences (NASDAQ: GILD) is nevertheless a consistent payer of such distributions. Reinforcing this, the company -- these days considered a coronavirus stock due to its COVID-19 drug remdesivir -- has declared its latest quarterly dividend.
A dividend of $0.68 per share will be handed out on Sept. 29 to investors of record as of Sept. 15. On Friday's closing stock price, this would yield 3.9%.
Since initiating its payout in February of 2015, the pharmaceutical company has dispensed it in every quarter. Over that stretch of time, it has increased gradually, from an initial $0.43 per share to the present level.
Source Fool.com
